GLUT3 is overexpressed in various cancer cells, such as glioblastoma (43), ovarian cancer (44), gastric cancer (45, 46), and non-small cell lung cancer (46), due to its high glycolytic efficiency. Here, SLC2A3 is linked to gastric cancer.